New eye treatment a ray of hope for millions of Indians

Nanoscope Therapeutics has introduced MOGENRY, a groundbreaking optogenetic gene therapy aimed at treating retinitis pigmentosa, which is currently under regulatory evaluation. This revolutionary single injection allows the remaining retinal cells to respond to light, raising hopes for enhanced vision. Early clinical trials in India indicated a positive outcome, with seven out of eight patients experiencing measurable vision improvement.

Sharing Is Caring:

Leave a Comment